EE200 A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs (NNIADS): Trends in Decision-Analytical Models (DAM) for Modelling of Type 2 Diabetes Mellitus (T2DM)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.450
https://www.valueinhealthjournal.com/article/S1098-3015(22)02654-7/fulltext
Title :
EE200 A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs (NNIADS): Trends in Decision-Analytical Models (DAM) for Modelling of Type 2 Diabetes Mellitus (T2DM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02654-7&doi=10.1016/j.jval.2022.09.450
First page :
Section Title :
Open access? :
No
Section Order :
12259